Oncoc4, Inc.
Clinical trials sponsored by Oncoc4, Inc., explained in plain language.
-
New hope for tough lung cancers: Next-Gen drug trial seeks to extend lives
Disease control Recruiting nowThis large, late-stage trial is testing whether a new immunotherapy drug called gotistobart (ONC-392) can help people live longer than standard chemotherapy for a specific type of advanced lung cancer. It is for adults whose metastatic non-small cell lung cancer has continued to …
Phase: PHASE3 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New Two-Pronged cancer drug enters human testing
Disease control Recruiting nowThis study is testing a new drug called AI-081 in people with advanced solid tumors that have spread or cannot be removed by surgery. The drug is designed to work in two ways at once by targeting two different pathways that help tumors grow. Researchers will first find the safest…
Phase: PHASE1, PHASE2 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC